![](https://mma.prnewswire.com/media/403578/Agenus_Logo.jpg?p=facebook)
Together with the scientists at Agenus, a US-based biotech company specializing in innovative forms of cancer treatment, including the discovery and development of immuno-oncology therapies, ABI has formed a team of students and researchers to study cancer metastases and identify potential biomarkers and targets for cancer immunotherapies. This collaboration is also part of our long-term vision of supporting biotech developments in Armenia. The team discovers transcriptomics heterogeneity of Liver metastases for precision diagnostics and treatment․
People
ABI Supervisors
![](https://abi.am/wp-content/uploads/2021/11/Hans_klor-3.png)
Hans Binder
University of Leipzig
ABI Chairman
![](https://abi.am/wp-content/uploads/2021/09/Arsen-Arakelyan.jpg)
Arsen Arakelyan
Institute of Molecular Biology NAS RA
ABI Board Member
![](https://abi.am/wp-content/uploads/2021/09/LN_photo2-Lilit-Nersisyan-1024x980.jpg)
Lilit Nersisyan
Karolinska Institutet, Sweden
Founding Director of ABI
ABI Research Students
![](https://abi.am/wp-content/uploads/2021/09/Ohanes.jpg)
![](https://abi.am/wp-content/uploads/2021/09/Nerses.jpg)
![](https://abi.am/wp-content/uploads/Yeva-Bareghamyan-1024x1024.png)